跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35 条关于
“Vymada”
全部
35
临床试验
8
药物
7
机构
9
资讯
11
去年
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
去年
Nyrada's NYR-BI03 Advances to Phase I Trials After Promising Preclinical Safety Results
去年
Kamada Announces Reduced Sample Size for Inhaled AAT Phase 3 Trial Following FDA Feedback
去年
Ocugen's OCU410 ArMaDa Trial Proceeds to Phase 2 for Geographic Atrophy
3个月前
Kamada Receives FDA Approval for In-House Rabies Virus Neutralization Testing Laboratory
去年
Kamada Receives FDA Approval for Houston Plasma Collection Center, Expanding Specialty Plasma Operations
9个月前
Kamada Discontinues Phase 3 Inhaled AAT Trial Following Futility Analysis, Maintains Strong Financial Outlook
5个月前
Kamada Secures FDA Approval for San Antonio Plasma Collection Center, Expanding Specialty Plasma Production Capacity
10个月前
Kamada Initiates SHIELD Trial to Prevent Late CMV Infection in High-Risk Kidney Transplant Recipients
2个月前
Omada Health to Report Second Quarter 2026 Financial Results on August 6
第 1 页,共 2 页
上一页
下一页